6.
Hagstrand Aldman M, Rasmussen M, Olaison L, Pahlman L
. Endocarditis due to Staphylococcus lugdunensis-a retrospective national registry-based study. Eur J Clin Microbiol Infect Dis. 2020; 40(5):1103-1106.
PMC: 8084830.
DOI: 10.1007/s10096-020-04134-w.
View
7.
Liu P, Huang Y, Tang C, Chen Y, Hsieh K, Ger L
. Staphylococcus lugdunensis infective endocarditis: a literature review and analysis of risk factors. J Microbiol Immunol Infect. 2011; 43(6):478-84.
DOI: 10.1016/S1684-1182(10)60074-6.
View
8.
Ambrosioni J, Hernandez-Meneses M, Tellez A, Pericas J, Falces C, Tolosana J
. The Changing Epidemiology of Infective Endocarditis in the Twenty-First Century. Curr Infect Dis Rep. 2017; 19(5):21.
DOI: 10.1007/s11908-017-0574-9.
View
9.
Yamazaki K, Minakata K, Sakamoto K, Sakai J, Ide Y, Kawatou M
. A case of aggressive aortic prosthetic valve endocarditis aggressive caused by Staphylococcus lugdunensis. Surg Case Rep. 2020; 6(1):280.
PMC: 7644629.
DOI: 10.1186/s40792-020-01062-x.
View
10.
Heilbronner S
. Staphylococcus lugdunensis. Trends Microbiol. 2021; 29(12):1143-1145.
DOI: 10.1016/j.tim.2021.07.008.
View
11.
Sabe M, Shrestha N, Gordon S, Menon V
. Staphylococcus lugdunensis: a rare but destructive cause of coagulase-negative staphylococcus infective endocarditis. Eur Heart J Acute Cardiovasc Care. 2014; 3(3):275-80.
DOI: 10.1177/2048872614523350.
View
12.
Bashore T, Cabell C, Fowler Jr V
. Update on infective endocarditis. Curr Probl Cardiol. 2006; 31(4):274-352.
DOI: 10.1016/j.cpcardiol.2005.12.001.
View
13.
Stout K, Daniels C, Aboulhosn J, Bozkurt B, Broberg C, Colman J
. 2018 AHA/ACC Guideline for the Management of Adults With Congenital Heart Disease: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol. 2018; 73(12):1494-1563.
DOI: 10.1016/j.jacc.2018.08.1028.
View
14.
Duhon B, Dallas S, Velasquez S, Hand E
. Staphylococcus lugdunensis bacteremia and endocarditis treated with cefazolin and rifampin. Am J Health Syst Pharm. 2015; 72(13):1114-8.
DOI: 10.2146/ajhp140498.
View
15.
Nilsson M, Bjerketorp J, Wiebensjo A, Ljungh A, Frykberg L, Guss B
. A von Willebrand factor-binding protein from Staphylococcus lugdunensis. FEMS Microbiol Lett. 2004; 234(1):155-61.
DOI: 10.1016/j.femsle.2004.03.024.
View
16.
Chen K, Sun M, Tsai A, Sun C, Wu W, Lai C
. Endophthalmitis: Case Series and Literature Review. Antibiotics (Basel). 2022; 11(11).
PMC: 9686588.
DOI: 10.3390/antibiotics11111485.
View
17.
Sims J, Anavekar N, Bhatia S, OHoro J, Geske J, Chandrasekaran K
. Clinical, Radiographic, and Microbiologic Features of Infective Endocarditis in Patients With Hypertrophic Cardiomyopathy. Am J Cardiol. 2017; 121(4):480-484.
DOI: 10.1016/j.amjcard.2017.11.010.
View
18.
Hunter N, Kusnik A, Proia L
. A Frequently Overlooked Contaminant: A Case of Staphylococcus lugdunensis Bacteremia. J Community Hosp Intern Med Perspect. 2023; 13(4):107-108.
PMC: 10589021.
DOI: 10.55729/2000-9666.1201.
View
19.
Thuny F, Grisoli D, Collart F, Habib G, Raoult D
. Management of infective endocarditis: challenges and perspectives. Lancet. 2012; 379(9819):965-975.
DOI: 10.1016/S0140-6736(11)60755-1.
View
20.
Anguera I, Rio A, Miro J, Matinez-Lacasa X, Marco F, Guma J
. Staphylococcus lugdunensis infective endocarditis: description of 10 cases and analysis of native valve, prosthetic valve, and pacemaker lead endocarditis clinical profiles. Heart. 2005; 91(2):e10.
PMC: 1768720.
DOI: 10.1136/hrt.2004.040659.
View